Odisha-based company’s COVID-19 rapid antigen test kit gets ICMR approval

By Sumit Blogs -

The Indian Council of Medical Research (ICMR) has validated the COVID-19 rapid antigen test kit developed by a private company in Odisha. The kit has been developed by IMGENEX India Pvt Ltd, Bhubaneswar with intellectual input from Regional Medical Research Centre (RMRC). The kit can detect various variants of COVID-19 by using nasopharyngeal swab samples.

RMRC director Dr Sanghamitra Pati said: “The IMGENEX India Pvt Ltd, Bhubaneswar first started developing the kit and RMRC Bhubaneswar provided intellectual support for in-house testing and validation. Subsequently, we submitted the proposal for approval.”

She said the kit ImCOV-Ag has very high sensitivity and specificity and can detect all variants of COVID-19.

The ICMR has approved the test kits based on the RMRC’s internal validation and a third party’s (an expert group from Kerala) report on efficacy and accuracy.

IMGENEX, CEO, Dr Sujay Singh said they started work on the kit in June 2021 and ICMR has approved it on Thursday following certain procedures.

He said with existing facilities, the firm can manufacture 2 lakh kits which can be ramped up to 20 lakh kits per month. Singh said that the kit is likely to be available in the market in two months.

Since it is the first such kit in eastern India, the states in this region can easily avail the facility. Singh said the market price of the kit will be lower than others now available in the market.

The ICMR, has so far validated as many as 150 Antigen based Rapid Test Kits (including 31 revalidations), sources in the health department said.

Credits – Source – https://bit.ly/3ILkcPP

The post Odisha-based company’s COVID-19 rapid antigen test kit gets ICMR approval appeared first on Stay in Gurgaon.

Comments

Post a Comment

Popular posts from this blog

Flat sale of flu drugs hints at no unusual rise in infections

By Sumit Blogs -
Image
By Economic Times – Flat sale of flu drugs hints at no unusual rise in infections Industry executives and chemists said the April sales data showed a month-on-month decline of 30-40%. But even though the lockdown is seen to be impacting sales of most drugs, the pattern for medicines for infections and flus is no different.Last Updated: Apr 30, 2020, 11.23 AM ISTAgenciesExperts said the decline in sales was primarily because of the lockdown and other restrictions which forced people to stay indoors. (This story originally appeared in on Apr 30, 2020)NEW DELHI: Sales of anti-infectives (antibiotics and antivirals), respiratory drugs, painkillers and analgesics — some key medicines used for influenza-like illnesses — have remained mostly unchanged in last three months (January to March), partly explained by the lockdown but also indicating no unusual rise in flu-type infections that might point to a wider and undetected spread of Covid-19. Sales of most medicines, including this set of
Read more

10YearsForSimha: Reasons behind film’s success

By Sumit Blogs -
Image
By Times of India – 10YearsForSimha: Reasons behind film’s success TIMESOFINDIA.COM | Last updated on – Apr 30, 2020, 06:00 ISTclose01/6Take a look at the reasons behind the film’s successDirected by Boyapati Srinu, the 2010 film Simha was a game-changer among Tollywood films that was lauded, not only for Nandamuri Balakrishna’s intense performance in the dual role but also the gripping narration of the filmmaker. Balayya and Nayanthara were seen on the big screen for the first time ever in the film. The action drama made a special place in the hearts of the audience because of its simple storytelling, superhit songs and unbeatable chemistry between the lead pair. The movie has completed a decade, but the essence is as fresh as it was back then. As the film clocks 10 years of its release, find out the reasons behind the massive success of the Balakrishna starrer.readmore02/6​Boyapati Srinu’s gripping narrationBefore Simha, Boyapati Srinu had delivered Bhadra (2005) and Tulasi (2007),
Read more

Hrithik-Saif’s Vikram Vedha hits a roadblock

By Sumit Blogs -
Image
The stage was about to be set for Hrithik Roshan and Saif Ali Khan’s ‘Vikram Vedha’ in Mumbai’s Film City. The material had reached. The artisans had been hired. But the lights have now been dimmed. Madhavan and Vijay Sethupathi’s hit movie Vikram Vedha’s Hindi remake will not go on floors by mid-July as per the original plan. The new delta virus of COVID has sent shudders down many spines and many films which were being laid out on an expansive scale have been either held back or shifted their shoots abroad. The first schedule of this Hrithik-Saif movie will now be shot abroad. A source says, “The Mumbai schedule will be done but later.” Adds the source, “It’s a call that was taken yesterday. It wasn’t an easy call to take, no doubt, but the fact that it’s going to be a costly set made the makers take the safer route rather than be sorry later.” When contacted, General Secretary of FWICE (Federation of Western India Cine Employees), Ashok Dubey, confirmed that the makers of ‘V
Read more